Skip to main content
. 2019 Jun 13;14(6):e0218071. doi: 10.1371/journal.pone.0218071

Table 1. Patient characteristics at baseline.

AMIS ARIP CLOZ OLAN QUET RISP RLAI ZIPR OLAI PALI PP1M
total population (N) N = 736 N = 921 N = 713 N = 2650 N = 2229 N = 2096 N = 869 N = 164 N = 393 N = 599 N = 844
1. Gender n % n % n % n % n % n % n % n % n % n % n %
male 281 38% 348 38% 314 44% 1160 44% 767 34% 835 40% 414 48% 61 37% 187 48% 230 38% 357 42%
2. Age at baseline mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD
age at baseline (years),
mean (SD)
49,3 15,0 43,7 13,7 49,2 15,5 47,9 14,7 53,6 17,4 52,1 17,0 46,7 14,6 46,8 14,2 43,7 13,6 46,5 13,4 47,2 13,0
median perc. median perc. median perc. median perc. median perc. median perc. median perc. median perc. median perc. median perc. median perc.
age at baseline (years),
median (25–75 percentile)
50 38–60 42 33–54 50 37–60 49 37–58 54 40–66 53 39–64 46 35–58 46,5 36–56 43 32–54 46 36–56 47 38–57
n % n % n % n % n % n % n % n % n % n % n %
Age = 0–19 20 2% 30 1% 16 1% 29 1%
Age = 20–29 68 9% 127 14% 67 9% 287 11% 185 8% 191 9% 115 13% 16 10% 67 17% 63 11% 82 10%
Age = 30–39 141 19% 252 27% 145 20% 514 19% 334 15% 333 16% 196 23% 34 21% 99 25% 137 23% 173 20%
Age = 40–49 151 21% 194 21% 126 18% 551 21% 386 17% 344 16% 181 21% 38 23% 90 23% 136 23% 216 26%
Age = 50–59 184 25% 216 23% 179 25% 701 26% 522 23% 511 24% 190 22% 48 29% 74 19% 161 27% 212 25%
Age = 60–69 120 16% 82 9% 122 17% 365 14% 346 16% 354 17% 132 15% 15 9% 52 13% 71 12% 129 15%
Age = 70–79 49 7% 23 2% 44 6% 152 6% 235 11% 196 9% 46 5% 24 4% 25 3%
Age = 80–89 13 2% 19 3% 46 2% 186 8% 123 6%
3. Time since diagnosis a mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD
no. of months since 1st recorded
F20 diagnosis—Mean(SD)
64,13 31,98 59,31 32,89 70,28 28,23 58,70 34,20 51,88 35,66 54,71 35,56 58,83 34,84 66,88 28,99 61,92 35,08 63,09 32,15 76,67 30,33
n % n % n % n % n % n % n % n % n % n % n %
n (%) patients with < 6 months 58 7,88% 87 9,45% 38 5,33% 337 12,72% 393 17,63% 337 16,08% 129 14,84% 52 13,23% 54 9,02% 42 4,98%
n (%) patients with 6-<12 months 23 3,13% 36 3,91% 13 1,82% 98 3,70% 78 3,50% 90 4,29% 32 3,68% 10 2,54% 19 3,17%
n (%) patients with 12-<24 months 52 7,07% 80 8,69% 29 4,07% 201 7,58% 207 9,29% 175 8,35% 52 5,98% 10 6,10% 30 7,63% 39 6,51% 32 3,79%
n (%) patients with 24-<36 months 37 5,03% 68 7,38% 27 3,79% 160 6,04% 190 8,52% 130 6,20% 45 5,18% 13 7,93% 16 4,07% 30 5,01% 38 4,50%
n (%) patients with 36-<48 months 48 6,52% 52 5,65% 36 5,05% 141 5,32% 141 6,33% 114 5,44% 47 5,41% 21 5,34% 31 5,18% 34 4,03%
n (%) patients with >48 months 518 70,38% 598 64,93% 570 79,94% 1713 64,64% 1220 54,73% 1250 59,64% 564 64,90% 124 75,61% 264 67,18% 426 71,12% 689 81,64%

a time since first diagnosis appearance in the database—does not necessarily indicate the first diagnosis ever, as date of first diagnosis is not recorded; data before 2002 were not available